NIA SBIR Phase I
Supports small businesses developing aging and memory technologies at the feasibility stage.
The National Institute on Aging (NIA) SBIR Phase I program funds feasibility-stage R&D by U.S. small businesses working on aging biology, Alzheimer's disease, and AD-related dementias (AD/ADRD). NIA administers the largest source of early-stage funding for aging-related R&D among all federal agencies, providing approximately $150 million per year in combined SBIR and STTR grants to small businesse…
Phase I feasibility R&D by small businesses in aging biology, Alzheimer's disease, AD-related dementias, and aging-related interventions funded at nearly $150 million annually.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see the timeline